应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
06887 东阳光药
未开盘 03-24 16:08:20
41.900
+0.700
+1.70%
最高
42.000
最低
40.680
成交量
26.43万
今开
41.600
昨收
41.200
日振幅
3.20%
总市值
241.34亿
流通市值
46.93亿
总股本
5.76亿
成交额
1,094万
换手率
0.24%
流通股本
1.12亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
东阳光药(06887.HK)3月31日举行董事会会议审议及批准年度业绩
中金财经 · 03-19
东阳光药(06887.HK)3月31日举行董事会会议审议及批准年度业绩
港股异动 | 东阳光药(06887)盈喜后涨超3% 预期年度归母净利约2.7亿元 磷酸奥司他韦市场需求大幅增加
智通财经 · 03-16
港股异动 | 东阳光药(06887)盈喜后涨超3% 预期年度归母净利约2.7亿元 磷酸奥司他韦市场需求大幅增加
东阳光药(06887)发盈喜,预期2025年度归母净利润约2.7亿元 同比转亏为盈
智通财经 · 03-13
东阳光药(06887)发盈喜,预期2025年度归母净利润约2.7亿元 同比转亏为盈
每日卖空追踪 | 东阳光药 03月11日卖空量成交1000股,卖空比例为0.68%
市场透视 · 03-11
每日卖空追踪 | 东阳光药 03月11日卖空量成交1000股,卖空比例为0.68%
东阳光药03月11日主力净流出69.3万元 散户资金买入
市场透视 · 03-11
东阳光药03月11日主力净流出69.3万元 散户资金买入
每日卖空追踪 | 东阳光药 03月09日卖空量成交2.76万股,卖空比例为11.99%
市场透视 · 03-09
每日卖空追踪 | 东阳光药 03月09日卖空量成交2.76万股,卖空比例为11.99%
东阳光药03月09日主力净流出64.0万元 散户资金买入
市场透视 · 03-09
东阳光药03月09日主力净流出64.0万元 散户资金买入
东阳光药03月06日主力净流入48.8万元 散户资金抛售
市场透视 · 03-06
东阳光药03月06日主力净流入48.8万元 散户资金抛售
AI 制药竞速开启!礼来带头,全行业加速布局
制药网 · 03-06
AI 制药竞速开启!礼来带头,全行业加速布局
每日卖空追踪 | 东阳光药 03月05日卖空量成交1.58万股,卖空比例为7.72%
市场透视 · 03-05
每日卖空追踪 | 东阳光药 03月05日卖空量成交1.58万股,卖空比例为7.72%
国内AI制药再迎来该“AI+RNA”小分子创新药完成头例患者给药
动脉网 · 03-05
国内AI制药再迎来该“AI+RNA”小分子创新药完成头例患者给药
每日卖空追踪 | 东阳光药 03月04日卖空量成交4.31万股,卖空比例为8.61%
市场透视 · 03-04
每日卖空追踪 | 东阳光药 03月04日卖空量成交4.31万股,卖空比例为8.61%
东阳光药创历史新低
格隆汇 · 03-04
东阳光药创历史新低
广东东阳光药业股份有限公司(06887)2月无新增发行或股份变动,股本维持稳定
公告速递 · 03-03
广东东阳光药业股份有限公司(06887)2月无新增发行或股份变动,股本维持稳定
每日卖空追踪 | 东阳光药 03月02日卖空量成交12.42万股,卖空比例为31.73%
市场透视 · 03-02
每日卖空追踪 | 东阳光药 03月02日卖空量成交12.42万股,卖空比例为31.73%
每日卖空追踪 | 东阳光药 02月27日卖空量成交1.9万股,卖空比例为6.64%
市场透视 · 02-27
每日卖空追踪 | 东阳光药 02月27日卖空量成交1.9万股,卖空比例为6.64%
每日卖空追踪 | 东阳光药 02月25日卖空量成交1.37万股,卖空比例为3.27%
市场透视 · 02-25
每日卖空追踪 | 东阳光药 02月25日卖空量成交1.37万股,卖空比例为3.27%
东阳光药:中国国家药监局受理HEC-648注射液的临床试验申请
美股速递 · 02-24
东阳光药:中国国家药监局受理HEC-648注射液的临床试验申请
东阳光药(06887):靶向尼帕病毒G蛋白的单克隆抗体新药HEC-648注射液临床试验申请获中国国家药品监督管理局受理
智通财经 · 02-24
东阳光药(06887):靶向尼帕病毒G蛋白的单克隆抗体新药HEC-648注射液临床试验申请获中国国家药品监督管理局受理
东阳光药02月24日主力净流出50.3万元 散户资金买入
市场透视 · 02-24
东阳光药02月24日主力净流出50.3万元 散户资金买入
加载更多
公司概况
公司名称:
东阳光药
所属市场:
SEHK
上市日期:
--
主营业务:
广东东阳光药业股份有限公司是一家主要从事药物的研发、生产和商业化的中国公司。该公司专注于创新药,亦涉及改良型新药、仿制药和生物类似药。该公司的抗感染产品包括可威(磷酸奥司他韦),用于治疗流行性感冒(特别是甲型及乙型流行性感冒病毒),东卫恩(磷酸依米他韦),用于治疗丙型肝炎,及主要用于治疗敏感细菌引起的感染的仿制药,即克拉霉素、左氧氟沙星及盐酸莫西沙星。该公司的慢病治疗药物主要专注于治疗糖尿病、高尿酸血症、高血压及胃酸相关疾病,包括胰岛素产品及仿制药。该公司还关注肿瘤治疗领域。
发行价格:
--
{"stockData":{"symbol":"06887","market":"HK","secType":"STK","nameCN":"东阳光药","latestPrice":41.9,"timestamp":1774339700007,"preClose":41.2,"halted":0,"volume":264267,"delay":0,"changeRate":0.016990291262135818,"floatShares":112000000,"shares":576000000,"eps":2.080908,"marketStatus":"未开盘","change":0.7,"latestTime":"03-24 16:08:20","open":41.6,"high":42,"low":40.68,"amount":10941432,"amplitude":0.032039,"askPrice":41.9,"askSize":300,"bidPrice":41.88,"bidSize":2000,"shortable":3,"etf":0,"ttmEps":-0.754,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1774402200000},"marketStatusCode":0,"adr":0,"listingDate":1754496000000,"exchange":"SEHK","adjPreClose":41.2,"openAndCloseTimeList":[[1774315800000,1774324800000],[1774328400000,1774339200000]],"volumeRatio":0.7215898916224573,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06887","defaultTab":"news","newsList":[{"id":"2620464962","title":"东阳光药(06887.HK)3月31日举行董事会会议审议及批准年度业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2620464962","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620464962?lang=zh_cn&edition=full","pubTime":"2026-03-19 17:57","pubTimestamp":1773914223,"startTime":"0","endTime":"0","summary":"格隆汇3月19日丨东阳光药(06887.HK)宣布,董事会会议将于2026年3月31日(星期二)举行,藉以(其中包括)审议及批准公司及其附属公司截至2025年12月31日止年度的年度业绩及其发布,以及考虑派付末期股息(如有)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260319/32081854.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1191","06887"],"gpt_icon":0},{"id":"2619043391","title":"港股异动 | 东阳光药(06887)盈喜后涨超3% 预期年度归母净利约2.7亿元 磷酸奥司他韦市场需求大幅增加","url":"https://stock-news.laohu8.com/highlight/detail?id=2619043391","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619043391?lang=zh_cn&edition=full","pubTime":"2026-03-16 11:35","pubTimestamp":1773632142,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,东阳光药盈喜后涨超3%,截至发稿,涨3.01%,报43.1港元,成交额649.64万港元。消息面上,3月13日,东阳光药发布公告,截至2025年12月31日止年度,集团预期取得归母净利润约为人民币2.7亿元,相较去年同期取得归母净亏损约为人民币2.1亿元增加约228.57%。预期上述增加主要由于2025年下半年流感疫情同比显着高发,集团核心产品磷酸奥司他韦作为流感防治首选药物,凭借确切的疗效、良好的品牌口碑,市场需求同比大幅增加。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1414176.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","BK4588","06887","VXUS","BK1191"],"gpt_icon":0},{"id":"2619196638","title":"东阳光药(06887)发盈喜,预期2025年度归母净利润约2.7亿元 同比转亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2619196638","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619196638?lang=zh_cn&edition=full","pubTime":"2026-03-13 18:38","pubTimestamp":1773398337,"startTime":"0","endTime":"0","summary":"智通财经APP讯,东阳光药 发布公告,截至2025年12月31日止年度,集团预期取得归母净利润约为人民币2.7亿元,相较去年同期取得归母净亏损约为人民币2.1亿元增加约228.57%。预期上述增加主要由于2025年下半年流感疫情同比显着高发,集团核心产品磷酸奥司他韦作为流感防治首选药物,凭借确切的疗效、良好的品牌口碑,市场需求同比大幅增加。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1413727.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"东阳光药(06887)发盈喜,预期2025年度归母净利润约2.7亿元 同比转亏为盈","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06887"],"gpt_icon":0},{"id":"2618971364","title":"每日卖空追踪 | 东阳光药 03月11日卖空量成交1000股,卖空比例为0.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618971364","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618971364?lang=zh_cn&edition=full","pubTime":"2026-03-11 16:30","pubTimestamp":1773217838,"startTime":"0","endTime":"0","summary":"东阳光药北京时间03月11日,跌0.47%,卖空量成交1000股,较上一交易日减少91.07%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311163607a460b879&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311163607a460b879&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06887","BK1191"],"gpt_icon":0},{"id":"2618497135","title":"东阳光药03月11日主力净流出69.3万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2618497135","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618497135?lang=zh_cn&edition=full","pubTime":"2026-03-11 16:15","pubTimestamp":1773216931,"startTime":"0","endTime":"0","summary":"03月11日, 东阳光药股价跌0.47%,报收41.96元,成交金额617.9万元,换手率0.13%,振幅2.04%,量比0.50。东阳光药今日主力资金净流出69.3万元,上一交易日主力净流入102.2万元。该股近5个交易日上涨1.79%,主力资金累计净流出55.6万元;近20日主力资金累计净流入497.5万元,其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311161719a6b786f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311161719a6b786f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06887","BK1191"],"gpt_icon":0},{"id":"2618981376","title":"每日卖空追踪 | 东阳光药 03月09日卖空量成交2.76万股,卖空比例为11.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618981376","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618981376?lang=zh_cn&edition=full","pubTime":"2026-03-09 16:30","pubTimestamp":1773045038,"startTime":"0","endTime":"0","summary":"东阳光药北京时间03月09日,跌2.12%,卖空量成交2.76万股,较上一交易日减少57.86%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309163550a45ae9b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309163550a45ae9b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06887","BK1191"],"gpt_icon":0},{"id":"2618981344","title":"东阳光药03月09日主力净流出64.0万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2618981344","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618981344?lang=zh_cn&edition=full","pubTime":"2026-03-09 16:15","pubTimestamp":1773044151,"startTime":"0","endTime":"0","summary":"03月09日, 东阳光药股价跌2.12%,报收41.52元,成交金额949.9万元,换手率0.21%,振幅3.35%,量比0.62。东阳光药今日主力资金净流出64.0万元,上一交易日主力净流入48.8万元。该股近5个交易日下跌1.24%,主力资金累计净流入19.7万元;近20日主力资金累计净流入464.7万元,其中净流入天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309162004a6b1b7b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309162004a6b1b7b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","06887"],"gpt_icon":0},{"id":"2617680489","title":"东阳光药03月06日主力净流入48.8万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2617680489","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617680489?lang=zh_cn&edition=full","pubTime":"2026-03-06 16:16","pubTimestamp":1772784962,"startTime":"0","endTime":"0","summary":"03月06日, 东阳光药股价涨4.84%,报收42.42元,成交金额1607.4万元,换手率0.34%,振幅4.70%,量比1.09。东阳光药今日主力资金净流入48.8万元,上一交易日主力净流出73.3万元。该股近5个交易日下跌1.03%,主力资金累计净流入249.6万元;近20日主力资金累计净流入412.0万元,其中净流入天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306162203a6aa300d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306162203a6aa300d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","06887"],"gpt_icon":0},{"id":"2617638504","title":"AI 制药竞速开启!礼来带头,全行业加速布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2617638504","media":"制药网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617638504?lang=zh_cn&edition=full","pubTime":"2026-03-06 11:00","pubTimestamp":1772766028,"startTime":"0","endTime":"0","summary":"近日,礼来宣布,AI制药工厂LillyPod已投入运行。根据合作备忘录,镁睿化学将基于其高通量自动化实验室和AI技术平台,为默克中国提供化学合成及相关服务,加快分子合成速度,缩短产品开发周期。BMS与AI制药公司insitro合作部署,用于ALS新药小分子发现与优化。未来,随着礼来AI制药工厂的投运,以及大批企业合作的推进,制药行业的研发范式预计将实现从“人力密集型”到“算力密集型”的根本性变革。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306110307a6a9226e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306110307a6a9226e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1515","BK1593","02196","01477","06887","BK1191"],"gpt_icon":0},{"id":"2617542549","title":"每日卖空追踪 | 东阳光药 03月05日卖空量成交1.58万股,卖空比例为7.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617542549","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617542549?lang=zh_cn&edition=full","pubTime":"2026-03-05 16:30","pubTimestamp":1772699438,"startTime":"0","endTime":"0","summary":"东阳光药北京时间03月05日,跌1.94%,卖空量成交1.58万股,较上一交易日减少89.71%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305163545a6a5db17&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305163545a6a5db17&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06887","BK1191"],"gpt_icon":0},{"id":"2617573087","title":"国内AI制药再迎来该“AI+RNA”小分子创新药完成头例患者给药","url":"https://stock-news.laohu8.com/highlight/detail?id=2617573087","media":"动脉网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617573087?lang=zh_cn&edition=full","pubTime":"2026-03-05 09:48","pubTimestamp":1772675280,"startTime":"0","endTime":"0","summary":"近年来AI制药兴起,全球AI制药企业超350家,国内不少于100家。3月2日,晶泰科技孵化企业ReviR宣布,其小分子药物管线RTX-117完成头例受试者给药,正式进入临床开发阶段,有望为腓骨肌萎缩症、白质消融性白质脑病等神经系统疾病患者提供治疗方案。RTX-117结合晶泰科技AI+机器人药物研发平台与ReviR对RNA生物学的理解,通过抑制异常激活的ISR通路,恢复mRNA正常翻译,从分子根源治疗疾病,未来有望拓展至更多适应症。晶泰科技正强化其优势与商业化价值,先后与多家企业达成合作,东阳光药与其成立合资公司,构建长期、深度绑定的技术共生关系。有机构表示,AI技术正改变新药研发格局。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305100816a44d84db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305100816a44d84db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","01477","06887","BK1191"],"gpt_icon":0},{"id":"2617592407","title":"每日卖空追踪 | 东阳光药 03月04日卖空量成交4.31万股,卖空比例为8.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617592407","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617592407?lang=zh_cn&edition=full","pubTime":"2026-03-04 16:30","pubTimestamp":1772613037,"startTime":"0","endTime":"0","summary":"东阳光药北京时间03月04日,跌0.63%,卖空量成交4.31万股,较上一交易日减少71.57%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304163602a6a15219&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304163602a6a15219&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","06887"],"gpt_icon":0},{"id":"2617239592","title":"东阳光药创历史新低","url":"https://stock-news.laohu8.com/highlight/detail?id=2617239592","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617239592?lang=zh_cn&edition=full","pubTime":"2026-03-04 13:43","pubTimestamp":1772602983,"startTime":"0","endTime":"0","summary":"格隆汇3月4日丨东阳光药(06887.HK)跌2.41%,报40.5200港元,股价创历史新低,总市值233.66亿港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304135458a6a0b3ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304135458a6a0b3ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06887","BK1191"],"gpt_icon":0},{"id":"1163236597","title":"广东东阳光药业股份有限公司(06887)2月无新增发行或股份变动,股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1163236597","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1163236597?lang=zh_cn&edition=full","pubTime":"2026-03-03 17:29","pubTimestamp":1772530180,"startTime":"0","endTime":"0","summary":"2026年3月3日,广东东阳光药业股份有限公司发布截至2026年2月28日的股份变动月报表。公告显示,截至报告期末,公司注册股本为人民币576,656,047元,包含H股与内资股。其中H股法定/注册股份数为112,712,832股,内资股法定/注册股份数为463,943,215股,整体保持不变。公告同时披露,公司并无关于员工期权、可换股票据或其他相关权证的任何新增或变动,亦无任何购回、注销行为。公告由董事张英俊签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06887"],"gpt_icon":0},{"id":"2616336787","title":"每日卖空追踪 | 东阳光药 03月02日卖空量成交12.42万股,卖空比例为31.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616336787","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616336787?lang=zh_cn&edition=full","pubTime":"2026-03-02 16:30","pubTimestamp":1772440241,"startTime":"0","endTime":"0","summary":"东阳光药北京时间03月02日,跌2.1%,卖空量成交12.42万股,较上一交易日减少2.74%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302163630a730c9e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302163630a730c9e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06887","BK1191"],"gpt_icon":0},{"id":"2614830852","title":"每日卖空追踪 | 东阳光药 02月27日卖空量成交1.9万股,卖空比例为6.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614830852","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614830852?lang=zh_cn&edition=full","pubTime":"2026-02-27 16:30","pubTimestamp":1772181039,"startTime":"0","endTime":"0","summary":"东阳光药北京时间02月27日,涨4.18%,卖空量成交1.9万股,较上一交易日减少63.04%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227163558a725f5ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227163558a725f5ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","06887"],"gpt_icon":0},{"id":"2614062198","title":"每日卖空追踪 | 东阳光药 02月25日卖空量成交1.37万股,卖空比例为3.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614062198","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614062198?lang=zh_cn&edition=full","pubTime":"2026-02-25 16:30","pubTimestamp":1772008242,"startTime":"0","endTime":"0","summary":"东阳光药北京时间02月25日,跌3.98%,卖空量成交1.37万股,较上一交易日减少54.49%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225163607a71d5cc3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225163607a71d5cc3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","06887"],"gpt_icon":0},{"id":"1157927809","title":"东阳光药:中国国家药监局受理HEC-648注射液的临床试验申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1157927809","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1157927809?lang=zh_cn&edition=full","pubTime":"2026-02-24 17:38","pubTimestamp":1771925889,"startTime":"0","endTime":"0","summary":"近日,东阳光药宣布其研发的HEC-648注射液临床试验申请已获中国国家药品监督管理局正式受理。这一进展标志着该创新药物正式进入临床审评阶段,为后续研发工作奠定重要基础。HEC-648注射液作为公司重点推进的创新药项目,其审评进程备受市场关注。此次受理不仅体现了监管机构对该公司研发能力的认可,也为其未来产品管线注入新的动力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","06887"],"gpt_icon":0},{"id":"2613670791","title":"东阳光药(06887):靶向尼帕病毒G蛋白的单克隆抗体新药HEC-648注射液临床试验申请获中国国家药品监督管理局受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2613670791","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613670791?lang=zh_cn&edition=full","pubTime":"2026-02-24 17:37","pubTimestamp":1771925847,"startTime":"0","endTime":"0","summary":"智通财经APP讯,东阳光药(06887)发布公告,2026年2月24日,中国国家药品监督管理局药品审评中心(“药品审评中心”)正式受理本集团提交的靶向尼帕病毒G蛋白的单克隆抗体新药HEC-648注射液临床试验申请,预计将于2026年正式启动I期临床研究。本集团秉持“科学创制新药,品质健康生活”的使命,立项研发尼帕病毒抗体药物作为战略储备,既是布局新发突发传染病防控、践行行业价值,也是助力国家筑牢生物安全与公共卫生防线、服务“一体化健康”战略、提升医药核心技术自主可控与全球公共卫生治理话语权的关键行动。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1406716.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"东阳光药(06887):靶向尼帕病毒G蛋白的单克隆抗体新药HEC-648注射液临床试验申请获中国国家药品监督管理局受理","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","06887"],"gpt_icon":0},{"id":"2614618708","title":"东阳光药02月24日主力净流出50.3万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2614618708","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614618708?lang=zh_cn&edition=full","pubTime":"2026-02-24 16:15","pubTimestamp":1771920928,"startTime":"0","endTime":"0","summary":"02月24日, 东阳光药股价跌0.92%,报收43.22元,成交金额513.5万元,换手率0.11%,振幅4.36%,量比0.51。东阳光药今日主力资金净流出50.3万元,上一交易日主力净流出0万元。该股近5个交易日上涨2.90%,主力资金累计净流出168.8万元;近20日主力资金累计净流入368.2万元,其中净流入天数为6日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224161704a71908c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224161704a71908c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06887","BK1191"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0187},{"period":"1month","weight":-0.0377},{"period":"3month","weight":-0.0412},{"period":"6month","weight":-0.1628},{"period":"1year","weight":-0.3044},{"period":"ytd","weight":-0.0811}],"compareEarnings":[{"period":"1week","weight":-0.0311},{"period":"1month","weight":-0.0511},{"period":"3month","weight":-0.0293},{"period":"6month","weight":-0.0537},{"period":"1year","weight":0.0484},{"period":"ytd","weight":-0.0221}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"广东东阳光药业股份有限公司是一家主要从事药物的研发、生产和商业化的中国公司。该公司专注于创新药,亦涉及改良型新药、仿制药和生物类似药。该公司的抗感染产品包括可威(磷酸奥司他韦),用于治疗流行性感冒(特别是甲型及乙型流行性感冒病毒),东卫恩(磷酸依米他韦),用于治疗丙型肝炎,及主要用于治疗敏感细菌引起的感染的仿制药,即克拉霉素、左氧氟沙星及盐酸莫西沙星。该公司的慢病治疗药物主要专注于治疗糖尿病、高尿酸血症、高血压及胃酸相关疾病,包括胰岛素产品及仿制药。该公司还关注肿瘤治疗领域。","exchange":"SEHK","name":"东阳光药","nameEN":"SUNSHINE PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"东阳光药(06887)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供东阳光药(06887)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"东阳光药,06887,东阳光药股票,东阳光药股票老虎,东阳光药股票老虎国际,东阳光药行情,东阳光药股票行情,东阳光药股价,东阳光药股市,东阳光药股票价格,东阳光药股票交易,东阳光药股票购买,东阳光药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"东阳光药(06887)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供东阳光药(06887)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}